Senescent Cells
Aged or damaged cells that permanently stop dividing but refuse to die, quietly driving inflammation as they accumulate with age.
Plain English
Senescent cells are old or damaged cells that stop dividing but do not die. Instead of disappearing, they stick around and release a steady stream of inflammatory signals that irritate the tissue around them. As they build up with age, researchers think they drive much of the low-grade inflammation and tissue decline associated with getting older.
The Mechanism
A cell can become senescent after several kinds of stress: DNA damage, worn-down telomeres from repeated division, or a stray growth signal that looks like the early stage of cancer. In response, the cell permanently shuts off its ability to divide. This is originally a protective move, it stops a potentially damaged or precancerous cell from copying itself, but the cell does not then clean itself up and disappear the way a normal worn-out cell would.
Instead, senescent cells stay metabolically active and start secreting a mix of inflammatory proteins, growth factors, and tissue-degrading enzymes into their surroundings, a pattern researchers call the senescence-associated secretory phenotype, or SASP. That secretion recruits immune cells to clear the senescent cell away, but it also irritates and can even push nearby healthy cells toward senescence themselves, so a small pocket of these cells can have an outsized effect on the tissue around it.
A young, healthy immune system clears most senescent cells fairly quickly. That clearance slows with age, so senescent cells accumulate faster than they are removed, especially in fat tissue, cartilage, and blood vessel walls. In mouse studies, selectively clearing senescent cells extended healthy lifespan and delayed several age-related conditions, which is the finding that launched the search for senolytic drugs designed to clear these cells in humans; that work remains experimental.
Why It Matters
They are one of the clearest biological links between chronic low-grade inflammation and the diseases of aging.
Senescent cells are considered one of the core drivers of biological aging because they actively secrete inflammatory signals rather than simply sitting idle, so their accumulation is linked to the chronic low-grade inflammation tied to heart disease, insulin resistance, and slower tissue repair. A relatively small senescent cell burden can meaningfully affect surrounding healthy tissue through that secretion. This is why senescent cell burden is treated as a distinct piece of the aging picture alongside markers like epigenetic age and telomere length, even though there is no simple blood test for it yet. Senolytic drugs aimed at clearing these cells are in early human trials, but they are not an approved or established consumer intervention.
Common Misconception
Senescent cells are often described as simply old cells, but age at the cellular level is not what defines them. A cell becomes senescent after a specific stress signal, DNA damage, telomere shortening, or an oncogene trigger, permanently halts its division, and this can happen at any age; intense training stress or an injury can push cells into senescence in a young adult. The more important misconception is that senescence is a form of cell death. It is not: senescent cells actively resist apoptosis, the normal process that would eliminate damaged cells, and that resistance is exactly what lets them persist and keep secreting inflammatory signals for months or years. Senolytic compounds that clear senescent cells remain experimental and are not an approved therapy, so claims that a supplement clears senescent cells should be treated with real skepticism.
How to Improve It
3 Things to Remember
Senescent cells are damaged or stressed cells that permanently stop dividing but do not die, and they build up in tissue as the immune system's ability to clear them weakens with age.
They secrete an inflammatory mix called the senescence-associated secretory phenotype (SASP), which is thought to drive much of the chronic low-grade inflammation linked to aging.
Senescence is not cell death; senescent cells actively resist apoptosis, and senolytic drugs designed to clear them remain experimental, not an established consumer intervention.
Related Terms
Protocol
Turn what you've learned into daily practice
Protocol pulls your wearable and nutrition data together into a daily health score, morning brief, and AI coaching. All in one place.
Get started free